Applied Dna Sciences Stock Performance
| APDN Stock | USD 1.79 0.14 7.25% |
The firm shows a Beta (market volatility) of -2.17, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Applied DNA are expected to decrease by larger amounts. On the other hand, during market turmoil, Applied DNA is expected to outperform it. At this point, Applied DNA Sciences has a negative expected return of -1.99%. Please make sure to confirm Applied DNA's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Applied DNA Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Applied DNA Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:50 | Dividend Date 2019-11-01 | Last Split Date 2025-03-14 |
1 | Disposition of 135 shares by Shorrock Clay of Applied DNA at 13.2 subject to Rule 16b-3 | 12/31/2024 |
2 | Applied DNA Sciences Completes GMP Facility for mRNA Production, Eyes 30M Revenue Potential - StockTitan | 01/10/2025 |
3 | Applied DNA Sciences Holds Special Meeting of Stockholders | 01/27/2025 |
4 | Disposition of 1250 shares by Shorrock Clay of Applied DNA at 47.6 subject to Rule 16b-3 | 02/07/2025 |
5 | Applied DNA Sciences GAAP EPS of -0.56 misses by 0.23, revenue of 1.2M beats by 0.02M | 02/13/2025 |
6 | Applied DNA signals growth with GMP facility launch and LineaRx focus in 2025 | 02/14/2025 |
7 | Applied DNA Sciences fails to secure quorum at special meeting - Investing.com India | 02/28/2025 |
8 | Acquisition by Catell Robert B of 13606 shares of Applied DNA at 11.04 subject to Rule 16b-3 | 03/05/2025 |
9 | Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Galveston County Daily News | 03/14/2025 |
10 | Acquisition by Jantzen Beth of 1961 shares of Applied DNA at 1.08 subject to Rule 16b-3 | 03/18/2025 |
11 | Applied DNA Sciences Research Coverage Started at StockNews.com | 03/20/2025 |
| Begin Period Cash Flow | 7.9 M |
Applied |
Applied DNA Relative Risk vs. Return Landscape
If you would invest 896.00 in Applied DNA Sciences on December 24, 2024 and sell it today you would lose (717.00) from holding Applied DNA Sciences or give up 80.02% of portfolio value over 90 days. Applied DNA Sciences is currently does not generate positive expected returns and assumes 9.966% risk (volatility on return distribution) over the 90 days horizon. In different words, 88% of stocks are less volatile than Applied, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Applied DNA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied DNA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Applied DNA Sciences, and traders can use it to determine the average amount a Applied DNA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1997
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APDN |
Estimated Market Risk
| 9.97 actual daily | 89 89% of assets are less volatile |
Expected Return
| -1.99 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Applied DNA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Applied DNA by adding Applied DNA to a well-diversified portfolio.
Applied DNA Fundamentals Growth
Applied Stock prices reflect investors' perceptions of the future prospects and financial health of Applied DNA, and Applied DNA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Applied Stock performance.
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.64 | ||||
| Profit Margin | (2.28) % | ||||
| Operating Margin | (2.48) % | ||||
| Current Valuation | (6.72 M) | ||||
| Shares Outstanding | 1.1 M | ||||
| Price To Earning | (5.06) X | ||||
| Price To Book | 0.15 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 3.43 M | ||||
| Gross Profit | 1.47 M | ||||
| EBITDA | (14.02 M) | ||||
| Net Income | (7.09 M) | ||||
| Cash And Equivalents | 4.68 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 739.16 K | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 2.16 X | ||||
| Book Value Per Share | 11.78 X | ||||
| Cash Flow From Operations | (13.71 M) | ||||
| Earnings Per Share | (32.50) X | ||||
| Market Capitalization | 1.98 M | ||||
| Total Asset | 12.79 M | ||||
| Retained Earnings | (309.67 M) | ||||
| Working Capital | 5.65 M | ||||
| Current Asset | 11.35 M | ||||
| Current Liabilities | 4.08 M | ||||
About Applied DNA Performance
By examining Applied DNA's fundamental ratios, stakeholders can obtain critical insights into Applied DNA's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Applied DNA is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 76.25 | 94.02 | |
| Return On Tangible Assets | (63.57) | (66.75) | |
| Return On Capital Employed | (63.57) | (60.39) | |
| Return On Assets | (63.57) | (60.39) | |
| Return On Equity | (63.57) | (60.39) |
Things to note about Applied DNA Sciences performance evaluation
Checking the ongoing alerts about Applied DNA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Applied DNA Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Applied DNA Sciences generated a negative expected return over the last 90 days | |
| Applied DNA Sciences has high historical volatility and very poor performance | |
| Applied DNA Sciences may become a speculative penny stock | |
| Applied DNA Sciences has a very high chance of going through financial distress in the upcoming years | |
| Applied DNA Scienceshas 5,605,294 shares shorted by Applied DNA investors is about 500% of outstending shares | |
| The company reported the previous year's revenue of 3.43 M. Net Loss for the year was (7.09 M) with profit before overhead, payroll, taxes, and interest of 1.47 M. | |
| Applied DNA Sciences currently holds about 4.68 M in cash with (13.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Applied DNA Sciences Research Coverage Started at StockNews.com |
- Analyzing Applied DNA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Applied DNA's stock is overvalued or undervalued compared to its peers.
- Examining Applied DNA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Applied DNA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Applied DNA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Applied DNA's stock. These opinions can provide insight into Applied DNA's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (32.50) | Revenue Per Share | Quarterly Revenue Growth 0.343 | Return On Assets | Return On Equity |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.